Don't listen to social media -- only NWBO SEC filings, FDA Guidance documents, TLD data, company press releases, clinicaltrials.gov -- the whole story is spelled out in those sources.
Conflict of interest with clinicians -- Dr. Liau is on NWBO's payroll as their Scientific Advisory Board.
I'll believe it when the FDA gets the application filing with all the protocol manipulations, etc. That will be the only things that count. Dr. Ashcan is having a challenge getting peer-review of the trial data manuscript -- it has been over 6 months.
Market Data 
Markets 
AI
